Tue, Sep 16, 2014, 12:22 PM EDT - U.S. Markets close in 3 hrs 38 mins

Recent

% | $
Quotes you view appear here for quick access.

HALLMARK VENTURE GRP Message Board

  • joeton55 joeton55 Apr 16, 2011 12:44 PM Flag

    Looks like the $245 million Hail Pharma deal may close by April 30

    http://dhnet.webdisclosure.com/actualite.html?id=113377

    The investment manager for Gulf General Insurance, Union Insurance, Al Mal
    Capital, and Sheikh Abdulla Bin Mohamed Bin Butti Al Hamed is H.E. Adel
    Al-Hosani and can be reached at +9712-6662800 begin_of_the_skype_highlighting +9712-6662800 end_of_the_skype_highlighting.

    Upon the execution of the reverse merger, name change and change of
    business, the company will have a total of approximately 50,015,500 shares
    outstanding and its opening balance sheet will have no less than EUR50
    million in cash and or cash equivalent (non-rated corporate short-term
    notes, 90 days, 4% interest, conversion feature) as well as EUR150 million
    in long-term corporate debentures (non-rated corporate debenture with
    conversion feature) for a total of $200,000,000 USD in net Assets and no
    liabilities and therefore EUR8.00 per share of net assets. In addition to
    the Assets, a total of 24,500,000 shares are issued and reserved for
    acquisitions valued at over EUR245,000,000. The company's market makers
    expect to begin trading post reverse split at EUR10.00 per common shares.

    Website

    Hail First Pharma Inc. is currently constructing a website which will be
    hosted at the following URL: www.hailfirstpharma.com

    Mailing Address:

    The main address for management will be at the following:

    Hail First Pharma Inc.
    Dubai Airport Free Trade Zone
    PO BOX 54620
    Dubai, 54620, United Arab Emirates

    Operational Addresse(s)

    The operational addresses, laboratories and research facilities will remain
    at their current locations in Canada and France. The said locations are
    that of a series of partnerships being acquired and are expected to be
    concluded by end of April 2011.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • http://dhnet.webdisclosure.com/actualite.html?id=113377

      DGAP-News: Zoloto Ventures / Key word(s): Merger/Corporate Action
      Zoloto Ventures: Announces Corporate Action(s)

      13.04.2011 / 15:50

      ---------------------------------------------------------------------


      " Upon the execution of the reverse merger, name change and change of
      business, the company will have a total of approximately 50,015,500 shares
      outstanding and its opening balance sheet will have no less than EUR50
      million in cash and or cash equivalent (non-rated corporate short-term
      notes, 90 days, 4% interest, conversion feature) as well as EUR150 million
      in long-term corporate debentures (non-rated corporate debenture with
      conversion feature) for a total of $200,000,000 USD in net Assets and no
      liabilities and therefore EUR8.00 per share of net assets. In addition to
      the Assets, a total of 24,500,000 shares are issued and reserved for
      acquisitions valued at over EUR245,000,000. The company's market makers
      expect to begin trading post reverse split at EUR10.00 per common shares.

      Website

      Hail First Pharma Inc. is currently constructing a website which will be
      hosted at the following URL: www.hailfirstpharma.com

      Mailing Address:

      The main address for management will be at the following:

      Hail First Pharma Inc.
      Dubai Airport Free Trade Zone
      PO BOX 54620
      Dubai, 54620, United Arab Emirates

      Operational Addresse(s)

      The operational addresses, laboratories and research facilities will remain
      at their current locations in Canada and France. The said locations are
      that of a series of partnerships being acquired and are expected to be
      concluded by end of April 2011.

      About Hail First Pharma

      Hail First Pharma is a pharmaceutical company specializing in acquiring,
      licensing and distributing of diabetic drugs, drug delivery technology,
      nutritional products and medical equipment.

      Contact:
      Zoloto Ventures/

      Hail First Pharma Inc. DRG Advisors LLC

      Hussain Al-Awaid Robert Albi
      Chairman President
      hailfirstpharma@gmail.com Tel. 516-351-8562


      End of Corporate News

      ---------------------------------------------------------------------

    • Game is on :)

 
HLLK
0.050.00(0.00%)Mar 15 9:30 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.